Articles of the Month
Videos
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Articles
Presentation of airway and general symptoms in COVID-19 caused by dominant SARS-CoV-2 variants: a follow-up on ARIA consensus
Hagemann, J., Onorato, G., Seifen, C., et al. Allergy. First published: 22 June 2022
Food allergy, mechanisms, diagnosis and treatment: Innovation through a multi-targeted approach
Sindher, S.B., Long, A., Chin, A.R., et al. Allergy. First published: 22 June 2022
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Worm, M., Alexiou, A., Bauer, A., et al. Allergy. First published: 20 June 2022
Structural and functional analyses of antibodies specific for modified core N-glycans suggest a role in TH2 responses
Plum, M., Tjerrild, L., Raiber, T., et al. Allergy. First published: 20 June 2022
Local production of broadly cross-reactive IgE against multiple fungal cell wall polysaccharides in patients with allergic fungal rhinosinusitis
Haruna, S., Takeda, K., El-Hussien, M.A., et al. Allergy. First published: 18 June 2022
Intranasal antihistamine and corticosteroid to treat in allergic rhinitis: A systematic review and meta-analysis
Kim, M., Ryu, G., Kang, S.-Y., et al. Allergy. First published: 18 June 2022
Absence of NLRP3 somatic mutations and VEXAS-related UBA1 mutations in a large cohort of patients with Schnitzler syndrome
Louvrier, C., Awad, F., Amselem, S., Lipsker, D. and Giurgea, I. Allergy. First published: 14 June 2022
Omics technologies in allergy and asthma research: an EAACI position paper
Radzikowska, U., Baerenfaller, K., Cornejo-Garcia, J.A., et al. Allergy. First published: 17 June 2022
CRISPR screening reveals mechanisms of IgE+ B-cell constraint
Awan, S.F., Haque, T.T. and Kubala, S.A. Allergy. First published: 16 June 2022
Cell type eQTL deconvolution of bronchial epithelium through integration of single-cell and bulk RNA-seq
Qi, C., Berg, M., Chu, X., et al. Allergy. First published: 16 June 2022
High-dimensional immune profiles correlate with phenotypes of peanut allergy during food-allergic reactions
Klueber, J., Czolk, R., Morel-Codreanu, F., et al. Allergy. First published: 14 June 2022
Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection
Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post–infection and post-vaccination cellular SARS-CoV-2-specific immune response
Kratzer, B., Schlax, L.C., Gattinger, P., et al. Allergy. First published: 12 June 2022
IL-13, an essential cDC2s partner to maintain skin homeostasis
Fernández-Santamaría, R., Cañas, J.A. and Aranda, C. Allergy. First published: 12 June 2022
Prenatal antibiotic exposure, asthma and the atopic march: A systematic review and meta-analysis
Cait, A., Wedel, A., Arntz, J.L., et al. Allergy. First published: 11 June 2022
Impact of time-varying confounders on the association between early-life allergy sensitization and the risk of current asthma: a post-hoc analysis of a birth cohort
Owora, A.H., Li, R., Tepper, R.S., et al. Allergy. First published: 10 June 2022
Soluble ST2 enhances IL-33–induced neutrophilic and pro-type 2 inflammation in the lungs
Watanabe, M., Nakamoto, K., Inui, T., et al. Allergy. First published: 05 June 2022
Legends of allergy and immunology: Richard F. Lockey
Fernandez-Caldas, E. Allergy. First published: 04 June 2022
Secretory RAS cells: A novel AT2 progenitor in the human transitional bronchioles
McGrath, J.J.C. and Cass, S.P. Allergy. First published: 04 June 2022
A recombinant multimeric dog allergen prevents airway hyperresponsiveness in a model of asthma marked by vigorous TH2 and TH17 cell responses
Stark, J.M., Liu, J., Tibbitt, C.A., et al. Allergy. First published: 03 June 2022
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Rose, R., Neumann, F., Müller, S., et al. Allergy. First published: 02 June 2022
The SCF/KIT axis in human mast cells: Capicua acts as potent KIT repressor and ERK predominates PI3K
Franke, K, Kirchner, M, Mertins, P, et al. Allergy. First published: 02 June 2022
Cow's milk and egg protein threshold dose distributions in children tolerant to beef, baked milk, and baked egg
Valluzzi, RL, Riccardi, C, Arasi, S, et al. Allergy. First published: 02 June 2022
Signatures of positive selection are enriched in genome-wide associated allergy alleles
Li, J., Zhang, X., Gao, Y., et al. Allergy. First published: 02 June 2022
Correspondence to " Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis"
Kelleher, M.M., Cro, S., Phillips, R., et al. Allergy. First published: 29 May 2022
Reply to correspondence: Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis
Zhong, Y., Samuel, M., van Bever, H. and Tham, E.H. Allergy. First published: 29 May 2022
Nanobody-based human antibody formats act as IgE surrogate in hymenoptera venom allergy
Aagaard, J.B., Sivelle, C., Fischer, M., et al. Allergy. First published: 29 May 2022
Monkeypox outbreak in Europe, UK, North America, and Australia: A changing trend of a zoonotic disease
Cabanillas, B., Valdelvira, R. and Akdis, C.A. et al. Allergy. First published: 29 May 2022
Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma
Ooka, T, Raita, Y, Fujiogi, M, et al. et al. Allergy. First published: 27 May 2022
Desert dust and respiratory diseases: Further insight on the epithelial barrier hypothesis
D’Amato, G. and Akdis, C.A. et al. Allergy. First published: 27 May 20222
Remission of peanut allergy is associated with rewiring of allergen-driven T helper 2-related gene networks
Ashley, SE, Jones, AC, Anderson, D, et al. Allergy. First published: 25 May 2022
NLRP6 negatively regulates type 2 immune responses in mice
Chenuet, P, Marquant, Q, Fauconnier, L, et al. Allergy. First published: 25 May 2022
Functional CTLA-4 variants associate to both allergic asthma and rhinitis potentially by modulating naïve regulatory T cells
Andiappan, A.K., Puan, K.J., Sio, Y.Y., et al. Allergy. First published: 24 May 2022
Synthetic antigenic determinants of clavulanic acid induce dendritic cell maturation and specific T cell proliferation in patients with immediate hypersensitivity reactions
Fernandez-Santamaria, R, Bogas, G, Montañez, MI, et al. Allergy. First published: 24 May 2022
The importance of threshold dose-distribution data for priority allergens and the need for future studies
Graham, F. and Fiocchi, A. Allergy. First published: 24 May 2022
The role of hypoxia in the pathophysiology of chronic rhinosinusitis
Zhong, B, Seah, JJ, Liu, F, et al. Allergy. First published: 23 May 2022
Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study
Carraro, S., di Palmo, E., Licari, A., et al. Allergy. First published: 23 May 2022
RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asthma in Greece: evaluating the multiple components of response
Kallieri, M., Zervas, E., Fouka, E., et al. Allergy. First published: 20 May 2022
Citations: 1421
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 409
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Citations: 258
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Citations: 206
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Citations: 192
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Citations: 159
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Citations: 91
Type 2 immunity in the skin and lungs
Akdis, CA, Arkwright, PD, Brüggen, MC, et al. Allergy. 2020; 75: 1582– 1605
Citations: 87
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Citations: 69
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444
Citations: 69
Towards a more precise diagnosis of hypersensitivity to beta-lactams — an EAACI position paper
Romano, A, Atanaskovic-Markovic, M, Barbaud, A, et al. Allergy. 2020; 75: 1300– 1315
Citations: 69
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Unexplained recurrent fever: when is autoinflammation the explanation?
Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course
Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Johnston, S.,L. Allergy. 2020; 75: 1543-1545
Immune-inflammatory proteome of elite ice hockey players before and after SARS-CoV-2 infection
Maurer, D.J., Barletta, E., Heider, A., et al. Allergy. First published: 12 June 2022
Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post–infection and post-vaccination cellular SARS-CoV-2-specific immune response
Kratzer, B., Schlax, L.C., Gattinger, P., et al. Allergy. First published: 12 June 2022
T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022
Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 14 May 2022
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab
Francis, C.H.R., Hearn, A.P., Ratnakumar, S., et al. Allergy. First published: 01 May 2022
Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study
Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022
Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern
Rothen, D.A., Krenger, P.S., Nonic, A., et al. Allergy. First published: 11 April 2022
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022
Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants
Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022
Are health care policies for COVID-19 evidence-based?
Bonini, S. and Fiorito, S. Allergy. First published: 30 March 2022
Virus-related stimuli modulate SARS-CoV-2 entry factor expression in pediatric tonsillar epithelial cells in vitro
Hara, M., Morimoto, N., Watabe, T., et al. Allergy. First published: 29 March 2022
Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID-19 vaccines?
Eberlein, B., Sonja, M., Fischer, J., Darsow, U., Biedermann, T. and Brockow, K. Allergy. First published: 10 March 2022
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
Has the Spring 2020 lockdown modified the relationship between air pollution and COVID-19 mortality in Europe?
Annesi-Maesano, I., Maesano, C.N., Dessimond, B., et al. Allergy. First published: 25 February 2022
Omicron: A SARS-CoV-2 variant of real concern
Gattinger, P., Tulaeva, I., Borochova, K., et al. Allergy. First published: 21 February 2022
Comparative assessment of allergic reactions to COVID-19 vaccines in Europe and the United States
Hatziantoniou, S., Anastassopoulou, C., Lampropoulou, V., et al. Allergy. First published: 16 February 2022
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19
Sokolowska, M., Rovati, G., Diamant, Z., et al. Allergy. First published: 16 February 2022
Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19
Sadlier, C., Albrich, W.C., Neogi, et al. Allergy. First published: 12 February 2022
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations
Jutel, M., Torres, M.J., Palomares, O., et al. Allergy. First published: 11 February 2022
Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 06 February 2022
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study
Horn, MP, Jonsdottir, HR, Brigger, D, et al. Allergy. First published: 05 January 2022
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Junior Members Corner
Dear Junior Members,
Do not miss the Master Class on Adolescents and Young Adults!
It will take place in person on 20-21 May 2022, in Geneva (Switzerland). The main goal of the Master Class is to understand the challenges faced by adolescents and young adults with allergies and asthma, why adolescents and young adults are at risk patients, and to learn how help adolescents and young adults better self-manage their allergies and asthma. The Master Class will be held by a panel of experts and the organising chairs are Dr G. Roberts, Dr M. Vazquez-Ortiz and Dr P. Eigenmann (also editor-in-chief of the EAACI Paediatric Allergy and Immunology Journal).
If you are interested in participating, you can find more information through the link.
Look forward to seeing you there!
Best regards,
The Junior Member Assembly
